1.2 List of Figures
Figure 1: Epidemiology Patterns for Atopic Dermatitis (million), 2016-2023 19
Figure 2: Epidemiology Patterns for Acne Vulgaris (million), 2016-2023 20
Figure 3: Epidemiology Patterns for Psoriasis (million), 2016-2023 21
Figure 4: Dermatology, Global, Key Marketed Products and Approved Indications, 2017 27
Figure 5: Dermatology Therapeutics Market, Global, Annual Revenue for Humira ($bn), 2006-2023 29
Figure 6: Dermatology Therapeutics Market, Global, Johnson & Johnson’s Annual Revenue for Remicade ($bn), 2006-2023 30
Figure 7: Dermatology Therapeutics Market, Global, Merck & Co.’s Annual Revenue for Remicade ($bn), 2010-2023 31
Figure 8: Dermatology Therapeutics Market, Global, Amgen’s Annual Revenue for Enbrel ($bn), 2006-2023 32
Figure 9: Dermatology Therapeutics Market, Global, Pfizer’s Annual Revenue for Enbrel ($bn), 2010-2023 33
Figure 10: Dermatology Therapeutics Market, Global, Annual Revenue for Stelara ($bn), 2010-2023 34
Figure 11: Dermatology Therapeutics Market, Global, Annual Revenue for Neoral ($m), 2006-2023 36
Figure 12: Dermatology Therapeutics Market, Global, Annual Revenue for Protopic ($m), 2006-2015 37
Figure 13: Dermatology Therapeutics Market, Global, Revenue Forecast for Cosentyx ($bn), 2016-2023 39
Figure 14: Dermatology Therapeutics Market, Global, Revenue Forecast for Dupilumab ($bn), 2017-2023 40
Figure 15: Dermatology Therapeutics Market, Global, Revenue Forecast for Taltz ($bn), 2017-2023 41
Figure 16: Dermatology Therapeutics Market, Global, Revenue Forecast for Taltz ($bn), 2016-2023 42
Figure 17: Dermatology Therapeutics Market, Global, Revenue Forecast for Eucrisa ($bn), 2016-2023 44
Figure 18: Dermatology Therapeutics Market, Global, Revenue Forecast for AMG-827 ($m), 2016-2022 45
Figure 19: Dermatology Therapeutics Market, Global, Overall Pharmaceutical Industry Pipeline by Therapy Area, 2017 50
Figure 20: Dermatology Therapeutics Market, Global, Pipeline for Dermatology by Stage of Development, Molecule Type and Program Type, 2017 52
Figure 21: Dermatology Therapeutics Market, Global, Pipeline for Key Dermatology Indications by Stage of Development, 2017 53
Figure 22: Dermatology Therapeutics Market, Global, Pipeline for Key Dermatology Indications by Molecule Type, 2017 54
Figure 23: Dermatology Therapeutics Market, Global, Pipeline for Dermatology by Molecular Target, 2017 55
Figure 24: Dermatology Therapeutics Market, Global, Pipeline for Dermatology by Molecular Target, 2017 55
Figure 25: Dermatology Therapeutics Market, Global, Pipeline for Key Dermatology Indications by Molecular Target, 2017 56
Figure 26: Dermatology Therapeutics Market, Global, Clinical Trial Attrition Rates by Stage of Development (%), 2006-2017 57
Figure 27: Dermatology Therapeutics Market, Global, Clinical Trial Attrition Rates by Stage of Development and Indication (%), 2006-2016 58
Figure 28: Dermatology Therapeutics Market, Global, Clinical Trial Attrition Rates by Stage of Development and Molecule Type (%), 2006-2016 59
Figure 29: Dermatology Therapeutics Market, Global, Clinical Trial Attrition Rates by Stage of Development and Molecular Target (%), 2006-2016 60
Figure 30: Dermatology Therapeutics Market, Global, Clinical Trial Duration by Stage of Development (months), 2006-2017 61
Figure 31: Dermatology Therapeutics Market, Global, Clinical Trial Duration by Stage of Development and Indication (months), 2006-2017 62
Figure 32: Dermatology Therapeutics Market, Global, Clinical Trial Duration by Stage of Development and Molecule Type (months), 2006-2016 63
Figure 33: Dermatology Therapeutics Market, Global, Clinical Trial Duration by Stage of Development and Molecular Target (months), 2006-2016 64
Figure 34: Dermatology Therapeutics Market, Global, Clinical Trial Size by Stage of Development (patients), 2006-2016 65
Figure 35: Dermatology Therapeutics Market, Global, Clinical Trial Size by Stage of Development and Indication (participants), 2006-2016 66
Figure 36: Dermatology Therapeutics Market, Global, Clinical Trial Size by Stage of Development and Molecule Type (participants), 2006-2016 67
Figure 37: Dermatology Therapeutics Market, Global, Clinical Trial Size by Stage of Development and Molecular Target (participants), 2006-2016 68
Figure 38: Dermatology Therapeutics Market, Global, Clinical Program Size by Stage of Development (months), 2006-2016 69
Figure 39: Dermatology Therapeutics Market, Global, Clinical Program Size by Stage of Development and Indication (participants), 2006-2016 70
Figure 40: Dermatology Therapeutics Market, Global, Clinical Program Size by Stage of Development and Molecule Type (participants), 2006-2016 71
Figure 41: Dermatology Therapeutics Market, Global, Clinical Program Size by Stage of Development and Molecular Target (participants), 2006-2017 72
Figure 42: Dermatology Therapeutics Market, Global, Revenue Forecast for Risankizumab ($m), 2016-2022 73
Figure 43: Dermatology Therapeutics Market, Global, Revenue Forecast for Zorblisa ($m), 2017-2023 75
Figure 44: Dermatology Therapeutics Market, Global, Revenue Forecast for Olumacostat glasaretil ($m), 2019-2023 76
Figure 45: Dermatology Therapeutics Market, Global, Revenue Forecast for Guselkumab ($m), 2016-2022 77
Figure 46: Dermatology Global, Market Size ($bn), 2016-2023 79
Figure 47: Dermatology Global, Annual Revenue Forecast for Key Products ($bn), 2016-2023 81
Figure 48: Dermatology, Global, Annual Revenue Forecast for Tumor Necrosis Factor-Alpha Inhibitors ($bn), 2016-2023 83
Figure 49: Dermatology, Global, Annual Revenue Forecast for Interleukin Inhibitors ($bn), 2015-2022 84
Figure 50: Dermatology, Global, Annual Revenue Forecast for Calcineurin Inhibitors ($bn), 2015-2022 85
Figure 51: Dermatology, Global, Annual Revenue Forecast for Glucocorticosteroids ($m), 2015-2022 86
Figure 52: Dermatology, Global, Annual Revenue Forecast for Phosphodiesterase 4 inhibitors ($bn), 2015-2023 87
Figure 53: Dermatology Therapeutics Market, Global, Cluster by Growth and Market Share, 2016-2023 88
Figure 54: Dermatology Therapeutics Market, Global, Forecast Market Share by Company (%), 2016-2023 92
Figure 55: Dermatology, Global, Companies by Compound Annual Growth Rate (%), 2016-2023 93
Figure 56: Dermatology, Global, Revenues by Product Type, 2016-2023 94
Figure 57: Dermatology, Global, Novartis, Annual Revenue Forecast ($bn), 2016-2023 95
Figure 58: Dermatology, Global, AbbVie Annual Revenue Forecast ($bn), 2016-2023 96
Figure 59: Dermatology, Global, Johnson & Johnson Annual Revenue Forecast ($bn), 2015-2022 97
Figure 60: Dermatology, Global, Sanofi, Annual Revenue Forecast ($bn), 2015-2022 98
Figure 61: Dermatology, Global, Pfizer Annual Revenue Forecast ($bn), 2015-2022 99
Figure 62: Dermatology, Global, Celgene Annual Revenue Forecast ($bn), 2016-2023 100
Figure 63: Dermatology, Global, Companies by Type, 2017 101
Figure 64: Dermatology, Global, Pipeline, High-Activity and Late-Stage Developers by Level of Dermatology Specialization, 2017 102
Figure 65: Dermatology, Global, Proportion of Total Company Revenue Attributed to Dermatology, 2015-2022 103
Figure 66: Dermatology, Global, Licensing Deals, 2006-2017 105
Figure 67: Dermatology, Global, Licensing Deals by Indication, 2006-2017 106
Figure 68: Dermatology, Global, Licensing Deals, 2006-2017 107
Figure 69: Dermatology, Global, Licensing Deals by Molecule Type and Mechanism of Action, 2006-2017 108
Figure 70: Dermatology Therapeutics Market, Global, Licensing Deals, 2006-2017 (Part 1) 109
Figure 71: Dermatology Therapeutics Market, Global, Licensing Deals, 2006-2017 (Part 2) 110
Figure 72: Dermatology Therapeutics Market, Global, Licensing Deals, 2006-2017 (Part 3) 111
Figure 73: Dermatology Therapeutics Market, Global, Licensing Deals, 2006-2017 (Part 4) 112
Figure 74: Dermatology, Global, Co-development Deals, 2006-2017 113
Figure 75: Dermatology, Global, Co-development Deals by Indication, 2006-2017 114
Figure 76: Dermatology, Global, Co-development Deals, 2006-2017 115
Figure 77: Dermatology, Global, Co-development Deals by Molecule Type and Mechanism of Action, 2006-2017 116
Figure 78: Dermatology Therapeutics Market, Global, Co-development Deals, 2006-2017 (Part 1) 117
Figure 79: Dermatology Therapeutics Market, Global, Co-development Deals, 2006-2017 (Part 2) 117
Figure 80: Dermatology Therapeutics Market, Global, Co-development Deals, 2006-2017 (Part 3) 117
Figure 81: Dermatology Therapeutics Market, Global, Co-development Deals, 2006-2017 (Part 4) 118
Figure 82: Dermatology, Global, Table of all Clinical Stage Pipeline Products, 2016 Part 1 126
Figure 83: Dermatology, Global, Table of all Clinical Stage Pipeline Products, 2016 Part 2 127
Figure 84: Dermatology, Global, Table of all Clinical Stage Pipeline Products, 2016 Part 3 128
Figure 85: Dermatology, Global, Table of all Clinical Stage Pipeline Products, 2016 Part 4 129
Figure 86: Dermatology, Global, Table of all Clinical Stage Pipeline Products, 2016 Part 5 130
Figure 87: Dermatology, Global, Table of all Clinical Stage Pipeline Products, 2016 Part 6 131
Figure 88: Dermatology, Global, Table of all Clinical Stage Pipeline Products, 2016 Part 7 132